Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 150

1.

Changes in vascular calcification and bone mineral density in calcium supplement users from the Canadian Multi-center Osteoporosis Study (CaMOS).

Hulbert M, Turner ME, Hopman WM, Anastassiades T, Adams MA, Holden RM.

Atherosclerosis. 2019 Dec 16. pii: S0021-9150(19)31609-0. doi: 10.1016/j.atherosclerosis.2019.12.003. [Epub ahead of print]

PMID:
31859056
2.

Vertebral Fractures in Individuals With Type 2 Diabetes: More Than Skeletal Complications Alone.

Koromani F, Oei L, Shevroja E, Trajanoska K, Schoufour J, Muka T, Franco OH, Ikram MA, Zillikens MC, Uitterlinden AG, Krestin GP, Anastassiades T, Josse R, Kaiser SM, Goltzman D, Lentle BC, Prior JC, Leslie WD, McCloskey E, Lamy O, Hans D, Oei EH, Rivadeneira F.

Diabetes Care. 2020 Jan;43(1):137-144. doi: 10.2337/dc19-0925. Epub 2019 Oct 28.

PMID:
31658976
3.

N-Butyrylated hyaluronic acid ameliorates gout and hyperuricemia in animal models.

Li L, Wang D, Wang X, Bai R, Wang C, Gao Y, Anastassiades T.

Pharm Biol. 2019 Dec;57(1):717-728. doi: 10.1080/13880209.2019.1672755.

PMID:
31622116
4.

Is Rheumatoid Arthritis a Risk Factor for Fractures: A Systematic Review of Observational Studies.

Gupta A, Pipe SG, Towheed T, Anastassiades T.

Curr Rheumatol Rev. 2019 Jul 23. doi: 10.2174/1573397115666190723160312. [Epub ahead of print]

PMID:
31544696
5.

Post-Streptococcal Reactive Arthritis (PSRA).

Bawazir Y, Towheed T, Anastassiades T.

Curr Rheumatol Rev. 2019 Aug 8. doi: 10.2174/1573397115666190808110337. [Epub ahead of print]

PMID:
31393253
6.

A Low Molecular Weight Hyaluronic Acid Derivative Accelerates Excisional Wound Healing by Modulating Pro-Inflammation, Promoting Epithelialization and Neovascularization, and Remodeling Collagen.

Gao Y, Sun Y, Yang H, Qiu P, Cong Z, Zou Y, Song L, Guo J, Anastassiades TP.

Int J Mol Sci. 2019 Jul 30;20(15). pii: E3722. doi: 10.3390/ijms20153722.

7.

Predictors of imminent non-vertebral fracture in elderly women with osteoporosis, low bone mass, or a history of fracture, based on data from the population-based Canadian Multicentre Osteoporosis Study (CaMos).

Adachi JD, Berger C, Barron R, Weycker D, Anastassiades TP, Davison KS, Hanley DA, Ioannidis G, Jackson SA, Josse RG, Kaiser SM, Kovacs CS, Leslie WD, Morin SN, Papaioannou A, Prior JC, Shyta E, Silvia A, Towheed T, Goltzman D.

Arch Osteoporos. 2019 May 16;14(1):53. doi: 10.1007/s11657-019-0598-x.

PMID:
31098708
8.

Longitudinal assessment of health-related quality of life in osteoporosis: data from the population-based Canadian Multicentre Osteoporosis Study.

Hopman WM, Berger C, Joseph L, Morin SN, Towheed T, Anastassiades T, Adachi JD, Hanley DA, Prior JC, Goltzman D; CaMos Research Group.

Osteoporos Int. 2019 Aug;30(8):1635-1644. doi: 10.1007/s00198-019-05000-y. Epub 2019 May 8.

PMID:
31069440
9.

Chemical Modification of the N-Acetyl Moieties of Hyaluronic Acid from Streptococcus equi for Studies in Cytokine Production.

Bebe S, Anastassiades T.

Methods Mol Biol. 2019;1954:99-113. doi: 10.1007/978-1-4939-9154-9_9.

PMID:
30864127
10.

Frailty and Risk of Fractures in Patients With Type 2 Diabetes.

Li G, Prior JC, Leslie WD, Thabane L, Papaioannou A, Josse RG, Kaiser SM, Kovacs CS, Anastassiades T, Towheed T, Davison KS, Levine M, Goltzman D, Adachi JD; CaMos Research Group.

Diabetes Care. 2019 Apr;42(4):507-513. doi: 10.2337/dc18-1965. Epub 2019 Jan 28.

PMID:
30692240
11.

A novel quantitative approach to the measurement of abdominal aortic calcification as applied to the Canadian Multicenter Osteoporosis Study (CaMOS).

Grant M, Turner ME, Murray-Guenther J, Anastassiades T, Hopman WM, Adams SM, Jeronimo P, Nolan R, Adams MA, Holden RM.

Bone. 2017 Apr;97:201-208. doi: 10.1016/j.bone.2017.01.018. Epub 2017 Jan 19.

PMID:
28111356
12.

Rheological study of hyaluronic acid derivatives.

Chernos M, Grecov D, Kwok E, Bebe S, Babsola O, Anastassiades T.

Biomed Eng Lett. 2017 Jan 17;7(1):17-24. doi: 10.1007/s13534-017-0010-y. eCollection 2017 Feb.

13.

Human acetyl-CoA:glucosamine-6-phosphate N-acetyltransferase 1 has a relaxed donor specificity and transfers acyl groups up to four carbons in length.

Brockhausen I, Nair DG, Chen M, Yang X, Allingham JS, Szarek WA, Anastassiades T.

Biochem Cell Biol. 2016 Apr;94(2):197-204. doi: 10.1139/bcb-2015-0115. Epub 2015 Dec 15.

PMID:
26935656
14.

Ten-year incident osteoporosis-related fractures in the population-based Canadian Multicentre Osteoporosis Study - comparing site and age-specific risks in women and men.

Prior JC, Langsetmo L, Lentle BC, Berger C, Goltzman D, Kovacs CS, Kaiser SM, Adachi JD, Papaioannou A, Anastassiades T, Towheed T, Josse RG, Brown JP, Leslie WD, Kreiger N; CaMOS Research Group.

Bone. 2015 Feb;71:237-43. doi: 10.1016/j.bone.2014.10.026. Epub 2014 Nov 7.

15.

Chemically modified N-acylated hyaluronan fragments modulate proinflammatory cytokine production by stimulated human macrophages.

Babasola O, Rees-Milton KJ, Bebe S, Wang J, Anastassiades TP.

J Biol Chem. 2014 Sep 5;289(36):24779-91. doi: 10.1074/jbc.M113.515783. Epub 2014 Jul 22.

16.

Prospectively measured 10-year changes in health-related quality of life and comparison with cross-sectional estimates in a population-based cohort of adult women and men.

Hopman WM, Berger C, Joseph L, Zhou W, Prior JC, Towheed T, Anastassiades T, Adachi JD, Hanley DA, Papadimitropoulos EA, Kirkland S, Kaiser SM, Josse RG, Goltzman D; CaMos Research Group.

Qual Life Res. 2014 Dec;23(10):2707-21. doi: 10.1007/s11136-014-0733-5. Epub 2014 Jun 13.

17.

Effect of Anticholinergic Medications on Falls, Fracture Risk, and Bone Mineral Density Over a 10-Year Period.

Fraser LA, Adachi JD, Leslie WD, Goltzman D, Josse R, Prior J, Kaiser S, Kreiger N, Kovacs CS, Anastassiades TP, Papaioannou A; for the CaMos Research Group.

Ann Pharmacother. 2014 Aug;48(8):954-961. Epub 2014 May 9.

18.

Choice of lumbar spine bone density reference database for fracture prediction in men and women: a population-based analysis.

Leslie WD, Langsetmo L, Zhou W, Goltzman D, Kovacs CS, Prior J, Josse R, Olszynski WP, Davison KS, Anastassiades T, Towheed T, Hanley DA, Kaiser SM, Lentle B, Kreiger N; CaMos Research Group.

J Clin Densitom. 2014 Apr-Jun;17(2):295-300. doi: 10.1016/j.jocd.2013.09.003. Epub 2014 Mar 7.

19.

Longitudinal changes in calcium and vitamin D intakes and relationship to bone mineral density in a prospective population-based study: the Canadian Multicentre Osteoporosis Study (CaMos).

Zhou W, Langsetmo L, Berger C, Poliquin S, Kreiger N, Barr SI, Kaiser SM, Josse RG, Prior JC, Towheed TE, Anastassiades T, Davison KS, Kovacs CS, Hanley DA, Papadimitropoulos EA, Goltzman D; CaMos Research Group.

J Musculoskelet Neuronal Interact. 2013 Dec;13(4):470-9.

20.

N-acylated glucosamines for bone and joint disorders: effects of N-butyryl glucosamine on ovariectomized rat bone.

Anastassiades T, Rees-Milton K, Xiao H, Yang X, Willett T, Grynpas M.

Transl Res. 2013 Aug;162(2):93-101. doi: 10.1016/j.trsl.2013.04.002. Epub 2013 May 13.

PMID:
23680489
21.

The effect of glucosamine on glucose metabolism in humans: a systematic review of the literature.

Dostrovsky NR, Towheed TE, Hudson RW, Anastassiades TP.

Osteoarthritis Cartilage. 2011 Apr;19(4):375-80. doi: 10.1016/j.joca.2011.01.007. Epub 2011 Jan 18. Review.

22.

Dietary patterns and incident low-trauma fractures in postmenopausal women and men aged ≥ 50 y: a population-based cohort study.

Langsetmo L, Hanley DA, Prior JC, Barr SI, Anastassiades T, Towheed T, Goltzman D, Morin S, Poliquin S, Kreiger N; CaMos Research Group.

Am J Clin Nutr. 2011 Jan;93(1):192-9. doi: 10.3945/ajcn.110.002956. Epub 2010 Nov 10.

23.

Fragility fractures and the osteoporosis care gap in women: the Canadian Multicentre Osteoporosis Study.

Fraser LA, Ioannidis G, Adachi JD, Pickard L, Kaiser SM, Prior J, Brown JP, Hanley DA, Olszynski WP, Anastassiades T, Jamal S, Josse R, Goltzman D, Papaioannou A; CaMos Research Group.

Osteoporos Int. 2011 Mar;22(3):789-96. doi: 10.1007/s00198-010-1359-2. Epub 2010 Aug 4.

24.

Using the same bone density reference database for men and women provides a simpler estimation of fracture risk.

Langsetmo L, Leslie WD, Zhou W, Goltzman D, Kovacs CS, Prior J, Josse R, Olszynski WP, Davison KS, Anastassiades T, Towheed T, Hanley DA, Kaiser S, Kreiger N; CaMOS Research Group.

J Bone Miner Res. 2010 Oct;25(10):2108-14. doi: 10.1002/jbmr.112.

25.

Health-related quality of life in Canadian adolescents and young adults: normative data using the SF-36.

Hopman WM, Berger C, Joseph L, Towheed T, Prior JC, Anastassiades T, Poliquin S, Zhou W, Adachi JD, Hanley DA, Papadimitropoulos EA, Tenenhouse A; CaMos Research Group.

Can J Public Health. 2009 Nov-Dec;100(6):449-52.

26.

Dietary patterns in Canadian men and women ages 25 and older: relationship to demographics, body mass index, and bone mineral density.

Langsetmo L, Poliquin S, Hanley DA, Prior JC, Barr S, Anastassiades T, Towheed T, Goltzman D, Kreiger N; CaMos Research Group.

BMC Musculoskelet Disord. 2010 Jan 28;11:20. doi: 10.1186/1471-2474-11-20.

27.

Philip Hench, a Nobel link in the evolution of the Canada Gairdner International Awards.

Gordon DA, Anastassiades T.

J Rheumatol. 2010 Jan;37(1):195-8. doi: 10.3899/jrheum.091047. No abstract available.

PMID:
20040640
28.

Immunoassay of low to moderately abundant anionic proteins utilizing selective immobilization to chitosan-coated plates.

Rees-Milton KJ, Anastassiades TP.

Anal Biochem. 2010 Jan 15;396(2):310-2. doi: 10.1016/j.ab.2009.09.037. Epub 2009 Sep 24.

PMID:
19782041
29.

Relation between fractures and mortality: results from the Canadian Multicentre Osteoporosis Study.

Ioannidis G, Papaioannou A, Hopman WM, Akhtar-Danesh N, Anastassiades T, Pickard L, Kennedy CC, Prior JC, Olszynski WP, Davison KS, Goltzman D, Thabane L, Gafni A, Papadimitropoulos EA, Brown JP, Josse RG, Hanley DA, Adachi JD.

CMAJ. 2009 Sep 1;181(5):265-71. doi: 10.1503/cmaj.081720. Epub 2009 Aug 4.

30.

The impact of incident fractures on health-related quality of life: 5 years of data from the Canadian Multicentre Osteoporosis Study.

Papaioannou A, Kennedy CC, Ioannidis G, Sawka A, Hopman WM, Pickard L, Brown JP, Josse RG, Kaiser S, Anastassiades T, Goltzman D, Papadimitropoulos M, Tenenhouse A, Prior JC, Olszynski WP, Adachi JD; CaMos Study Group.

Osteoporos Int. 2009 May;20(5):703-14. doi: 10.1007/s00198-008-0743-7. Epub 2008 Sep 19.

31.

Geographic variation of bone mineral density and selected risk factors for prediction of incident fracture among Canadians 50 and older.

Langsetmo L, Hanley DA, Kreiger N, Jamal SA, Prior J, Adachi JD, Davison KS, Kovacs C, Anastassiades T, Tenenhouse A, Goltzman D; CaMos Research Group.

Bone. 2008 Oct;43(4):672-8. doi: 10.1016/j.bone.2008.06.009. Epub 2008 Jul 1.

32.

A multifaceted intervention to improve treatment of osteoporosis in postmenopausal women with wrist fractures: a cluster randomized trial.

Cranney A, Lam M, Ruhland L, Brison R, Godwin M, Harrison MM, Harrison MB, Anastassiades T, Grimshaw JM, Graham ID.

Osteoporos Int. 2008 Dec;19(12):1733-40. doi: 10.1007/s00198-008-0669-0. Epub 2008 Jul 16.

PMID:
18629567
33.

Inflammation and arthritis: perspectives of the glycobiologist.

Brockhausen I, Anastassiades TP.

Expert Rev Clin Immunol. 2008 Mar;4(2):173-91. doi: 10.1586/1744666X.4.2.173.

PMID:
20477049
34.

The association between body mass index and health-related quality of life: data from CaMos, a stratified population study.

Hopman WM, Berger C, Joseph L, Barr SI, Gao Y, Prior JC, Poliquin S, Towheed T, Anastassiades T; CaMos Research Group.

Qual Life Res. 2007 Dec;16(10):1595-603. Epub 2007 Oct 24.

PMID:
17957495
35.

The osteoporosis care gap in men with fragility fractures: the Canadian Multicentre Osteoporosis Study.

Papaioannou A, Kennedy CC, Ioannidis G, Gao Y, Sawka AM, Goltzman D, Tenenhouse A, Pickard L, Olszynski WP, Davison KS, Kaiser S, Josse RG, Kreiger N, Hanley DA, Prior JC, Brown JP, Anastassiades T, Adachi JD; CaMos Research Group.

Osteoporos Int. 2008 Apr;19(4):581-7. Epub 2007 Oct 9.

36.

Glucosamine therapy for osteoarthritis: an update.

Towheed TE, Anastassiades T.

J Rheumatol. 2007 Sep;34(9):1787-90. No abstract available.

PMID:
17787046
37.

Changes in body mass index in Canadians over a five-year period: results of a prospective, population-based study.

Hopman WM, Leroux C, Berger C, Joseph L, Barr SI, Prior JC, Harrison M, Poliquin S, Towheed T, Anastassiades T, Goltzman D; CaMos Research Group.

BMC Public Health. 2007 Jul 9;7:150.

38.
39.

Disease modifying effects of N-butyryl glucosamine in a streptococcal cell wall induced arthritis model in rats.

Wang SX, Cherian A, Dumitriu M, Grynpas MD, Carran J, Wainman D, Anastassiades T.

J Rheumatol. 2007 Apr;34(4):712-20. Epub 2007 Feb 15.

PMID:
17309122
40.

Single dose pharmacokinetics and bioavailability of butyryl glucosamine in the rat.

Aghazadeh-Habashi A, Ibrahim A, Carran J, Anastassiades T, Jamali F.

J Pharm Pharm Sci. 2006;9(3):359-64.

41.

What is the number of older Canadians needed to screen by measurement of bone density to detect an undiagnosed case of osteoporosis? a population-based study from CaMos.

Sawka AM, Papaioannou A, Josse RG, Murray TM, Ioannidis G, Hanley DA, Prior JC, Thabane L, Papadimitropoulos EA, Gafni A, Pickard L, Anastassiades T, Kirkland S, Adachi JD; CaMos Research Group.

J Clin Densitom. 2006 Oct-Dec;9(4):413-8. Epub 2006 Sep 1.

PMID:
17097526
42.

The action of TNFalpha and TGFbeta include specific alterations of the glycosylation of bovine and human chondrocytes.

Yang X, Yip J, Anastassiades T, Harrison M, Brockhausen I.

Biochim Biophys Acta. 2007 Feb;1773(2):264-72. Epub 2006 Sep 20.

44.

Prevalence of and factors associated with glucosamine use in Canada.

Hopman WM, Towheed TE, Gao Y, Berger C, Joseph L, Vik SA, Hanley DA, Carran J, Anastassiades T.

Osteoarthritis Cartilage. 2006 Dec;14(12):1288-93. Epub 2006 Jul 10.

45.

The natural progression of health-related quality of life: results of a five-year prospective study of SF-36 scores in a normative population.

Hopman WM, Berger C, Joseph L, Towheed T, VandenKerkhof E, Anastassiades T, Adachi JD, Ioannidis G, Brown JP, Hanley DA, Papadimitropoulos EA; CaMos Research Group.

Qual Life Res. 2006 Apr;15(3):527-36.

PMID:
16547791
46.

Driving problems in patients with rheumatoid arthritis.

Cranney AB, Harrison A, Ruhland L, Vaidyanath C, Graham I, Man-Son-Hing M, Jaffey J, Towheed TE, Anastassiades TP, Dwosh II.

J Rheumatol. 2005 Dec;32(12):2337-42.

PMID:
16331759
47.

N-acylation of glucosamine modulates chondrocyte growth, proteoglycan synthesis, and gene expression.

Terry DE, Rees-Milton K, Smith P, Carran J, Pezeshki P, Woods C, Greer P, Anastassiades TP.

J Rheumatol. 2005 Sep;32(9):1775-86.

PMID:
16142878
48.

N-Acyl derivatives of glucosamine as acceptor substrates for galactosyltransferase from bone and cartilage cells.

Brockhausen I, Carran J, McEleney K, Lehotay M, Yang X, Yin L, Anastassiades T.

Carbohydr Res. 2005 Sep 5;340(12):1997-2003.

PMID:
15993867
49.

Glucosamine therapy for treating osteoarthritis.

Towheed TE, Maxwell L, Anastassiades TP, Shea B, Houpt J, Robinson V, Hochberg MC, Wells G.

Cochrane Database Syst Rev. 2005 Apr 18;(2):CD002946. Review.

PMID:
15846645
50.

Biochemical markers for osteoarthritis: from the present to the future and back to the past.

Anastassiades T, Rees-Milton K.

J Rheumatol. 2005 Apr;32(4):578-9. No abstract available.

PMID:
15801009

Supplemental Content

Loading ...
Support Center